Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
Clinical trial NCT03351829 · UNKNOWN
Trial details
- NCT number
- NCT03351829
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.